Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention
- 1 May 1999
- Vol. 54 (5) , 507-510
- https://doi.org/10.1034/j.1398-9995.1999.00958.x
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease frequently associated with asthma, rhinitis, and food allergy. Lymphocytes producing Th2‐type cytokines (such as interleukin [IL]‐3, IL‐4, and IL‐5) have been thought to have a key role in the pathogenesis of the disease. We have recently demonstrated that elevated serum levels of the soluble form of CD30 (sCD30), an activation marker of Th2‐cell clones, correlates with disease activity in pediatric patients suffering from AD. Clinical trials have demonstrated that cyclosporin A (CyA) treatment resulted in significant improvement of clinical symptoms in patients affected with AD. In this study, we evaluated the role of CyA in modulating sCD30 release in a group of adult patients affected by severe AD treated with CyA at the dosage of 3.5 mg/kg body weight for 12 weeks. Our results demonstrated, in parallel with an improvement of clinical symptoms, a significant reduction of serum levels of both IL‐4 and sCD30, thus suggesting that CyA can prevent the activation of Th2 cells observed in AD.Keywords
This publication has 15 references indexed in Scilit:
- Cyclosporine restores cytokine imbalance in childhood atopic dermatitisJournal of Allergy and Clinical Immunology, 1997
- Soluble CD30 in pediatric patients with atopic dermatitisAllergy, 1997
- Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitisBritish Journal of Dermatology, 1997
- Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitisThe Journal of Pediatrics, 1996
- Cyclosporin in atopic dermatitis: a multicentre placebo-controlled studyBritish Journal of Dermatology, 1994
- Regulation of lnterleukin-5 Production by Peripheral Blood Mononuclear Cells from Atopic Patients with FK506, Cyclosporin A and GlucocorticoidInternational Archives of Allergy and Immunology, 1994
- Differential Cytokine Profiles in Peripheral Blood Lymphocyte Supernatants and Skin Biopsies from Patients with Different Forms of Atopic Dermatitis, Psoriasis and Normal IndividualsInternational Archives of Allergy and Immunology, 1994
- Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialBritish Journal of Dermatology, 1993
- Correlation of Eosinophils, Eosinophil Cationic Protein and Soluble lnterleukin-2 Receptor with the Clinical Activity of Atopic DermatitisDermatology, 1992
- High Frequency of IL-4–Producing CD4+ Allergen-Specific T Lymphocytes in Atopic Dermatitis Lesional SkinJournal of Investigative Dermatology, 1991